Startseite Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
Artikel Open Access

Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state

  • Lucie Hejnova , Anna Hronova , Zdenka Drastichova und Jiri Novotny EMAIL logo
Veröffentlicht/Copyright: 20. April 2024
Artikel downloaden (PDF)
Open Life Sciences
Aus der Zeitschrift Open Life Sciences Band 19 Heft 1

Abstract

We investigated the changes in redox state and protein expression in selected parts of the rat brain induced by a 4 week administration of morphine (10 mg/kg/day). We found a significant reduction in lipid peroxidation that mostly persisted for 1 week after morphine withdrawal. Morphine treatment led to a significant increase in complex II in the cerebral cortex (Crt), which was accompanied by increased protein carbonylation, in contrast to the other brain regions studied. Glutathione levels were altered differently in the different brain regions after morphine treatment. Using label-free quantitative proteomic analysis, we found some specific changes in protein expression profiles in the Crt, hippocampus, striatum, and cerebellum on the day after morphine withdrawal and 1 week later. A common feature was the upregulation of anti-apoptotic proteins and dysregulation of the extracellular matrix. Our results indicate that the tested protocol of morphine administration has no significant toxic effect on the rat brain. On the contrary, it led to a decrease in lipid peroxidation and activation of anti-apoptotic proteins. Furthermore, our data suggest that long-term treatment with morphine acts specifically on different brain regions and that a 1 week drug withdrawal is not sufficient to normalize cellular redox state and protein levels.

Keywords: morphine; withdrawal; brain; oxidative stress; proteomics

1 Introduction

Morphine is an effective drug for pain relief. However, its use is problematic as it causes many undesirable side effects, particularly dependence. There are currently a growing number of publications dealing with the cytotoxic or protective effects of chronic morphine treatment [1,2,3,4]. The cytotoxic effects of morphine are sometimes attributed to an increase in oxidative stress, but the effect of morphine on the oxidative state of cells is still controversial. There is evidence that chronic morphine treatment causes long-term changes in the regulation of signaling pathways that may persist even after the drug is discontinued [5,6,7,8,9,10].

In animal models, chronic administration of morphine was found to increase oxidative stress in brain tissue. Increased lipid peroxidation and decreased levels of reduced glutathione (GSH) [11,12,13] and decreased activity of manganese superoxide dismutase (SOD) and glutathione peroxidase (GPx) were found [14,15]. Interestingly, in contrast to animal studies, no change in GSH levels has been found in autopsies of the brains of heroin or cocaine addicts [16]. On the contrary, some studies have described the cytoprotective effects of morphine. In particular, the cardioprotective effects of pharmacological morphine preconditioning have been demonstrated in models of myocardial ischemia [17,18,19]. The neuroprotective effects of opioid preconditioning have been observed in various brain injuries and diseases such as stroke, neonatal hypoxia/ischemia, trauma, Parkinson’s disease, and Alzheimer’s disease [20,21,22,23,24]. One of the parameters frequently monitored was the oxidative state of brain tissue. In some studies, chronic morphine alone did not cause an increase in lipid peroxidation and a decrease in catalase (CAT) activity, while on the other hand, a progressive increase in lipid peroxidation and a decrease in CAT activity after ischemia were counterbalanced by chronic morphine [22]. The activity of SOD was not influenced by chronic morphine, and conversely, prior chronic administration of morphine suppressed the decrease in SOD activity after ischemia [25]. The involvement of oxidative stress has been demonstrated in many neurodegenerative diseases such as Parkinson’s and Alzheimer’s [26,27]. Importantly, chronic administration of morphine or other opioids has been shown to have beneficial effects in some experimental models of neurodegenerative diseases. The reduction of oxidative stress is considered one of the possible mechanisms [28].

Cell membranes are an essential component of cells. The plasma membrane not only separates the internal milieu of the cell from the external environment, but various signals are also specifically targeted and transmitted through this indispensable cellular structure. The mitochondrial membranes house the respiratory chain, which is important for adenosine triphosphate formation. Damage to either membrane can have significant consequences for cell survival.

The effect of morphine administration was also investigated at the level of changes in protein levels by proteomic studies [29]. From this perspective, morphine has been shown to lead to a significant dysregulation of biological pathways associated with extracellular matrix organization, cell adhesion, cytoskeleton, energy metabolism, and glutamate homeostasis [9,30,31].

We have previously reported that the administration of morphine in a single dose (10 mg/kg) for 10 days may have cardioprotective effects by reducing the susceptibility of the heart to ischemia-induced ventricular arrhythmias [17]. Similar protective effects were observed after the prolonged administration of the drug and our proteomic analyses of left ventricular tissue revealed a number of changes in myocardial protein expression after morphine administration and withdrawal [32,33]. A constant dose of 10 mg/kg morphine per day was used in various studies in rats [34,35,36,37]. In addition, long-term treatment with such a relatively high dose of morphine corresponds to the situation of drug addicts who can ingest similar amounts of the drug [38]. In the present study, we decided to investigate the consequences of prolonged morphine administration and morphine withdrawal in selected parts of the rat brain (cortex [Crt], hippocampus [Hip], striatum [Str], and cerebellum [Crb]). As mentioned earlier, morphine can affect the redox balance and potentially cause oxidative stress. Our specific aims were therefore initially to determine the effect of morphine on the extent of oxidative damage to cell membranes prepared from brain tissue. In this context, we decided to investigate the effect of morphine on the amount of reduced GSH, changes in the expression of respiratory chain complexes and antioxidant enzymes. The second aim was to determine the effects of morphine and its withdrawal on the overall expression of brain proteins using proteomic analysis.

2 Methods

2.1 Materials

Morphine sulfate was obtained from Saneca Pharmaceuticals, Ltd. (Hlohovec, Slovakia). Some of the basic chemicals (Tris, sucrose, glycine, Tween 20) were from Serva (Heidelberg, Germany). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).

2.2 Morphine treatment

Male Wistar rats (weighing 250–280 g) were maintained on a 12/12 light/dark cycle and had ad libitum access to food and water. The rats were divided into three groups of six animals each. The rats in the morphine group (M28) received 10 mg/kg morphine dissolved in 0.9% NaCl daily for 28 days. A withdrawal group of rats (M28/W) received morphine at the same dose for 28 days, followed by 7 days without the drug. The control rats (CON) received 0.9% NaCl. The rats in the CON and M28 groups were sacrificed 24 h after the last injection, and the rats in the M28/W group after the next 7 days. Samples of Crt, Hip, Str, and Crb were collected immediately, snap-frozen in liquid nitrogen, and stored at −80°C until use.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals and has been approved by the Ministry of Education, Youth and Sports of the Czech Republic 116 (Licence No. MSMT-1479/2019–6).

2.3 Sample preparation

The individual parts of the brain were pooled into experimental groups. The pooled samples of prefrontal Crt, Hip, Str, and Crb were homogenized in TMES buffer (20 mM Tris, 3 mM MgCl2, 1 mM ethylenediamine-tetraacetic acid (EDTA), and 0.25 M sucrose; pH 7.4) using a glass-Teflon homogenizer at 1,200 rpm for 2 min on ice [39]. About 50 µl of the 20% (w/v) homogenate was withdrawn and mixed 1:1 with 4% sodium deoxycholate (Sigma-Aldrich, St. Louis, MO, USA) and used for label-free protein quantification (MaxLFQ). Peptidase and phosphatase inhibitors (cOmplete, PhosSTOP, Roche Diagnostics, Basel, Switzerland) were immediately added to the remaining homogenates. The homogenates were clarified by centrifugation at 800 × g for 10 min at 4°C (Hettich Universal 320 R; Hettich, Germany). The resulting supernatants were centrifuged at 50,000 × g for 30 min at 4°C (Beckman Optima L-90K, rotor Ti50, Beckman, USA). The cytosolic fractions (supernatant) were kept, and the crude membrane fractions (pellet) were dissolved in TME buffer (20 mM Tris, 3 mM MgCl2, and 1 mM EDTA; pH 7.4). Both types of samples were aliquoted and rapidly frozen in liquid nitrogen. The protein content was measured by the bicinchonic acid method [39].

2.4 Lipid peroxidation

Lipid peroxidation was measured by malondialdehyde (MDA) formation using the thiobarbituric acid reactive substance (TBARS) assay [40] in crude membrane fractions. About 50 µg of protein diluted in 100 µl of TME was mixed with 200 µl of 10% trichloroacetic acid (TCA) and 300 µl of 0.67% thiobarbituric acid. The mixtures were heated at 100°C for 30 min. After cooling, the mixtures were centrifuged (Hettich Universal 320 R, Hettich, Germany) for 10 min at 10,000 rpm and 4°C. The supernatant (100 µl) was pipetted onto a 96-well plate, and the fluorescence intensity was read (λ ex/em = 540/590 nm) using plate reader (BioTek Synergy HT, Winooski, VA, USA). The same procedure was used for the standards, and the amounts of TBARS in the samples were calculated.

2.5 Lipid content

Lipids were isolated from crude membrane fractions using the Folch method [41]. The total amount of lipids in the samples was detected using a colorimetric method in microtiter plate format [42]. In brief, 360 µg of proteins in 65 µl of TME was sonicated with 40% potency (Sonopuls, Bandelin electronic, Berlin, Germany) for 10 s, then mixed with 1.3 ml of chloroform:methanol (2:1), and sonicated one more time. The solutions were centrifuged at 620 × g for 20 min at room temperature (RT), and the lipid extract in the chloroform:methanol fraction was then evaporated at 90°C for 20 min. The lipids were resuspended in 450 µl of chloroform:methanol, and 100 µl of the extracts was pipetted onto a plate and evaporated under the same conditions. Then, 150 µl of concentrated H2SO4 was added and incubated at 90°C for 10 min. The solution (100 µl) was pipetted into a new plate, and the background absorbance was measured at 540 nm. Then, 100 µl of vanillin–phosphoric acid reagent (0.2 mg vanillin to 1 ml 17% phosphoric acid) was added and incubated for 15 min at RT in the dark. The absorbance of the sample was measured at 540 nm using plate reader (BioTek Synergy HT, Winooski, VA, USA). The total amount of lipids in the samples was calculated using Brain Extract Total (Sigma-Aldrich, St. Louis, MO, USA) as a standard.

2.6 Protein carbonylation

The oxidation of the proteins in the crude membrane fractions was measured as the amount of carbonyls using a simplified spectrophotometric 2,4-dinitrophenylhydrazine (DNPH) assay [43]. About 500 µg of protein diluted in 200 µl of TME was mixed with 200 µl of 10 mM DNPH and incubated for 10 min at RT in the dark. Then, 100 µl of 6 M NaOH was added, vortexed vigorously, and incubated for a further 10 min. Then, 100 µl of the mixture was pipetted into a 96-well plate, and the absorbance was measured at 450 nm using plate reader (BioTek Synergy HT, Winooski, VA, USA). The concentration of carbonyl groups was calculated using the molar extinction coefficient of DNPH at 450 nm (ε = 22,308 M−1 cm−1). DNPH was dissolved in dimethyl sulfoxide (DMSO) and diluted in 2.5 M HCl (the final concentration of DMSO was 1%).

2.7 Reduced GSH

The amount of reduced GSH in the cytosolic fractions was determined by the Ellman method [44]. Briefly, 600 µg of protein diluted in 200 µl of TME was mixed with 200 µl of 10% TCA and incubated on ice for 10 min. After incubation, the mixture was centrifuged (Hettich Universal 320 R, Hettich, Tuttlingen, Germany) at 10,000 rpm for 10 min at 4°C. The supernatant (100 µl) was pipetted onto a 96-well plate, and 100 µl of 0.5 M Na2HPO4 (pH 8.4) and 20 µl of 1 mM 5,5′-dithio-bis-[2-nitrobenzoic acid] (DTNB) in 1% sodium citrate were added. The solution was incubated at RT for 10 min. The GSH standard curve was prepared in the same way. The absorbance of the samples was determined at 405 nm using plate reader (BioTek Synergy HT, Winooski, VA, USA), and the amount of reduced GSH was calculated from the standard curve.

2.8 Westerm blotting

Samples of the crude membrane fraction were solubilized in Laemmli buffer and loaded onto standard 10% polyacrylamide gels as described previously [45]. Electrophoresis was performed at 200 V for 45 min. Subsequently, the resolved proteins were transferred to a nitrocellulose membrane (Protran BA85, GE Healthcare, Little Chalfont, Buckinghamshire, UK) at 100 V for 90 min, blocked with 5% nonfat dry milk in TBS buffer (10 mM Tris and 150 mM NaCl; pH 8.0) for 30 min, and then incubated with specific primary antibodies overnight at 4°C. The respiratory chain proteins were detected with Total OXPHOS Rodent WB Antibody Cocktail (Abcam, Cambridge, UK) and Complex II (CII) 70 kDa (Invitrogen, Carlsbad, California, USA). The next day, the membranes were washed three times for 10 min with TBS buffer containing 0.3% Tween 20 (TBS-T), and secondary anti-mouse IgG antibodies conjugated to horseradish peroxidase (Amersham, Little Chalfont, UK) were applied for 1 h at RT. After washing three times for 10 min with TBS-T, the blots were visualized by enhanced chemiluminescence technique using SuperSignal West Dura substrate (Pierce Biotechnology, Rockford, IL, USA). Nitrocellulose membranes were stained with Ponceau S dye to verify uniform loading of each sample. The blots were scanned and quantitatively analyzed using ImageJ software. The band intensity in the Western blot was normalized to the total protein content (Ponceau staining).

2.9 MaxLFQ

The samples prepared for label-free quantification were processed as previously described [9]. They were reduced with 5 mM Tis-(2-carboxyethyl)-phosphine for 60 min at 60°C, and free cysteine residues were blocked by 10 mM methyl methanethiosulfonate in isopropanol and 10 min incubation at RT. Trypsin digestion was performed by adding 4 µg of trypsin to each sample and incubating for 12 h at 37°C. Trypsin cleavage was terminated by acidifying the reaction mixture with trifluoroacetic acid to a final concentration of 0.1%. Sodium deoxycholate was removed by extraction with two volumes of ethyl acetate (8,000 × g, 30 s). The aqueous phase containing the peptide mixture was added to SpeedVac for 20 min, and the samples were desalted using MacroTrap C18 cartridge (MICHROM Bioresources, Inc., Auburn, CA, USA). Finally, 2 µg of the peptide mixture was loaded onto the PepMap 300 C 18 column (5 mm × 300 μm ID, 5 μm particles, 300 Å pore size; 163589, Thermo Scientific, Waltham, MA, USA). Individual peptides were separated by high pressure liquid chromatography using an EASY-Spray column, 50 cm × 75 μm ID, PepMap C18, 2 μm particles, 100 Å pore size (ES 803, Thermo Scientific, Waltham, MA, USA). Peptides were separated using a linear gradient for 2 h between mobile phase A (2% acetonitrile, 0.1% formic acid) and B (80% acetonitrile, 0.1% formic acid). At the beginning of the separation, the system was run with 2% mobile phase B, followed by gradient elution to 40% B. The eluted peptide cations were converted to gas-phase ions by electrospray ionization and analyzed using a Thermo Orbitrap fusion mass spectrometer (Q-OT-qIT, Thermo Scientific, Waltham, MA, USA). Survey scans of peptide precursors from 400 to 1600 m/z were performed with a resolution of 120 K (at 200 m/z) and an ion count of 5 × 105. Tandem mass spectrometry was performed by isolation at 1.5 Th with quadrupole, HCD fragmentation with normalized collision energy of 30, and rapid scan MS analysis in the ion trap. The MS2 ion counting target was set to 104, and the maximum injection time was 35 ms. Only the precursors with charge states 2–6 were sampled for MS2. The dynamic exclusion time was set to 45 s with a tolerance of 10 ppm for the selected precursor and its isotope. The monoisotopic precursor selection was turned on. The instrument was operated in maximum speed mode with 2-s cycles.

2.10 Data analysis

At least three determinations were carried out in various experiments. For some measurements, a higher number of replicates were used in order to achieve better reproducibility and reliability of the results. The results were statistically analyzed using two-way ANOVA with Tukey’s multiple comparison test, and P values of less than 0.05 were considered significant. GraphPad Prism version 8 software (GraphPad Software Inc., La Jolla, CA, USA) was used for statistical analysis and graph generation. Proteomic data were analyzed and quantified using MaxQuant software (version 1.5.2.4., Planck Institute of Biochemistry, Munich, Germany). The false discovery rate was set to 1% for both proteins and peptides, and a minimum length of seven amino acids was specified. The Andromeda search engine was used to search MS/MS spectra against the UniProt Rattus norvegicus database of protein sequences. Enzyme specificity was set as C-terminal to Arg and Lys, with cleavage at proline bonds and a maximum of two failed cleavages also allowed. Dithiomethylation of cysteine was selected as fixed modification and N-terminal protein acetylation and methionine oxidation as variable modifications. The “match between runs” feature of MaxQuant was used to transfer identifications to other LC–MS/MS runs based on their masses and retention times (maximum deviation 0.7 min) to other LC–MS/MS runs; this was also used in quantification experiments. Quantifications were performed using the recently described label-free algorithms [46]. Binary logarithms of intensity ratios were then calculated for each group, and the difference between control and sample means were determined. Only the minimum 2-fold differences were considered, which were calculated for at least two readings from three replicates. Altered proteins were analyzed using the DAVID database for GO terms biological processes and cellular components [47]. Significant clusters of proteins with more than four or ten proteins (biological processes and cellular components, respectively) were considered.

3 Results

3.1 Oxidative damage to membranes

Chronic administration of morphine at a dose of 10 mg/kg/day for 28 days and subsequent withdrawal resulted in significantly decreased lipid peroxidation in samples of crude membranes prepared from all brain parts tested (Figure 1a). In the Crt, lipid peroxidation, as determined by measuring MDA production, was significantly reduced in animals killed immediately after 28 days of morphine administration (M28). However, after 7 days of withdrawal (M28/W), MDA levels returned to control values (CON). In the Str and Hip, MDA levels were significantly decreased after morphine administration (M28), and this decrease was exacerbated after the 7 day withdrawal (M28/W). A decreased amount of MDA was also detectable in the Crb, but the reduction was only significant in the RM28 group compared to the control group (CON). Total lipid levels in the crude membrane fraction were not altered by morphine treatment and withdrawal (Figure 1b).

Figure 1 Oxidative damage of cell membranes. Lipid peroxidation (a), total lipid content (b), protein carbonylation (c), and reduced GSH (d) were measured as described in the methods. Bars represent the mean ± standard error of the mean (SEM). Lipid peroxidation was measured as MDA formation six times in Crt and Str, five times in Hip and Crb, all measurement was done in tetraplicates. Protein carbonylation was determined five times in triplicate. Reduced GSH was measured four times in triplicate. Total lipid content was measured five times (striatum four times) in tetraplikates. Bars represent mean ± SEM (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001).
Figure 1

Oxidative damage of cell membranes. Lipid peroxidation (a), total lipid content (b), protein carbonylation (c), and reduced GSH (d) were measured as described in the methods. Bars represent the mean ± standard error of the mean (SEM). Lipid peroxidation was measured as MDA formation six times in Crt and Str, five times in Hip and Crb, all measurement was done in tetraplicates. Protein carbonylation was determined five times in triplicate. Reduced GSH was measured four times in triplicate. Total lipid content was measured five times (striatum four times) in tetraplikates. Bars represent mean ± SEM (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001).

Damage to the membrane and membrane-associated proteins was determined by measuring protein carbonylation (Figure 1c). The results showed that with the exception of the Crt, there was no change in protein carbonylation after morphine withdrawal. In the Crt of the M28 and M28/W groups, protein carbonylation increased by 10 and 15%, respectively. Interestingly, the level of protein carbonylation differed significantly between brain regions. Protein carbonylation increased in the following order: Crt < Hip < Str < Crb (Figure 1c).

The different parts of the rat brain also differed in the amount of reduced GSH, another parameter of redox balance (Figure 1d). Crt and Hip contained similar amounts of GSH in the control condition, while the content of this tripeptide was lower in the Str and significantly lower in the Crb. GSH content was significantly decreased in the Crt of M28 rats (by 10%) and in the Crb of M28/W rats (by 20%) compared to the corresponding controls. On the other hand, the GSH content in the Hip was not significantly altered after morphine withdrawal. In contrast, the GSH content was markedly increased in the Str of M28 (by 25%) and M28/W (by 35%) rats.

3.2 Respiratory chain

The proteins of the respiratory chain were analyzed by Western blotting with the Total OXPHOS Antibody Cocktail. CII was detected separately with a specific antibody. In most cases, there were no significant differences between the groups. The only change was found in the Crt, where a significantly increased amount of CII was observed in the M28 group (Figure 2).

Figure 2 Effect of morphine on the respiratory chain. Individual complexes (CI–CV) of the respiratory chain in samples of the Crt, Hip, Str, and Crb were assessed by Western blotting using Total OXPHOS Antibody Cocktail and specific anti-CII antibody. Bars represent the mean ± SEM from six separate experiments (** p ≤ 0.01).
Figure 2

Effect of morphine on the respiratory chain. Individual complexes (CI–CV) of the respiratory chain in samples of the Crt, Hip, Str, and Crb were assessed by Western blotting using Total OXPHOS Antibody Cocktail and specific anti-CII antibody. Bars represent the mean ± SEM from six separate experiments (** p ≤ 0.01).

3.3 Free protein quantification

Using LFQ, we determined 2,463 proteins in the Crt, 2,458 proteins in the Hip, 2,448 proteins in the Str, and 2,416 proteins in the Crb. The detected redox enzymes were not affected by morphine and withdrawal in any part of the brain (Table 1). However, various changes in the levels of some proteins (Table S1) and qualitative changes in the proteins were observed (Table S2). In general, a relatively equal number of proteins were upregulated or downregulated in all parts of the brain except the Crb. Obviously, increased levels were found for more proteins in the Crb than in other parts of the brain (Figure 3). The altered proteins were analyzed using the DAVID database. Based on the analysis of biological processes and cellular components (Table S3), several clusters of altered proteins were found. The analysis of biological processes revealed a protein cluster in all brain regions, representing the negative regulation of apoptotic processes. Another protein cluster was detected in the Str and seven other proteins in the Crb. Analysis of the cellular components of all parts of the brain revealed a cluster of proteins of extracellular exosomes, except in the Crt. No protein cluster was found in the cerebral Crt according to the selected parameters. Another protein cluster was detected in the Str. A total of seven protein clusters were distinguished in the Crb.

Table 1

Redox enzymes not affected by morphine

Protein ID Protein name Gene name
P04762 CAT Cat
P07632 SOD [Cu–Zn] Sod1
P07895 SOD [Mn], mitochondrial Sod2
P29476 Nitric oxide synthase, brain Nos1
P04041 Glutathione peroxidase 1 Gpx1
Q63716 Peroxiredoxin-1 Prdx1
P35704 Peroxiredoxin-2 Prdx2
Q9Z0V6 Thioredoxin-dependent peroxide reductase, mitochondrial Prdx3
Q9Z0V5 Peroxiredoxin-4 Prdx4
Q9R063 Peroxiredoxin-5, mitochondrial Prdx5
O35244 Peroxiredoxin-6 Prdx6
Figure 3 Total number of changed proteins in individual parts of the rat brain after morphine treatment. Dark blue – proteins upregulated in M28 and/or RM28, light blue – proteins detected in M28 and/or RM28, grey – proteins upregulated in M28 and downregulated in RM28, yellow – proteins downregulated in M28 and upregulated in RM28, dark red – proteins downregulated in M28 and/or RM28, light red – proteins not detected in M28 and/or RM28.
Figure 3

Total number of changed proteins in individual parts of the rat brain after morphine treatment. Dark blue – proteins upregulated in M28 and/or RM28, light blue – proteins detected in M28 and/or RM28, grey – proteins upregulated in M28 and downregulated in RM28, yellow – proteins downregulated in M28 and upregulated in RM28, dark red – proteins downregulated in M28 and/or RM28, light red – proteins not detected in M28 and/or RM28.

The expression of various proteins was altered in a similar way in all parts of the brain examined. Morphine treatment significantly decreased the levels of flotillin-1 and flotillin-2, and this effect was enhanced after 7 days of withdrawal. Another downregulated protein was metabotropic glutamate receptor 2 (mGLUR2). The level of this receptor was reduced in all parts of the brain except the Crb, and the decrease persisted after discontinuation of the drug. In the Crb, the level of mGLUR2 in the M28 group was below the detection limit of the method. Some proteins were upregulated in all parts of the brain. The 70 kDa heat shock protein (Hsp70) (1 A and 1B detected together) was increased in the M28 group. After the discontinuation of morphine (M28/W), the level of this protein decreased but remained significantly above the control value. Heat shock protein beta-1 (Hspb1) was also upregulated by morphine treatment. Higher levels of this protein were measured in the Hip, Str, and Crb in both experimental groups. The enzyme protein-arginine deiminase type-2 (PAD2) was upregulated in all parts of the brain, and the increased levels remained the same in the M28 and M28/W groups. Phospholipase C-delta1 (PLCdelta1) is another protein that was elevated in all parts of the brain. This protein was not detected in the Crt, Hip, and Crb of the control animals, but after morphine treatment, its levels rose above the detection limit. Only in the Str was PLCdelta1 detected in all experimental groups, and its levels were increased in both the M28 and RM28 groups. The change in PLCdelta1 expression after the 7 day withdrawal was no more than 2-fold different from that in the M28 group. Only in a few cases did protein levels return to control levels after morphine discontinuation (e.g., collagen type VI alpha 1 chain in the Hip and NADH-ubiquinone oxidoreductase chain 4, heat shock protein beta-1 and endoplasmic reticulum membrane protein complex subunit 8 in Str, sorbin and SH3 domain-containing protein 2, erythrocyte membrane protein band 4.1, filamin A, anion exchange protein, erythrocyte membrane protein band 4.2, tropomyosin alpha-1 chain, vimentin, alpha-crystallin B chain, and neurabin-1 in the Crb). On the other hand, the effect of morphine on some proteins was enhanced after discontinuation of the drug (e.g., myosin regulatory light chain 2 and myosin-6 in Crt, and myosin-6 in the Hip). Exceptionally, protein expression was opposite in the M28 and M28/W groups (e.g., collagen alpha-1(I) chain and collagen alpha-2(I) chain in the Crt, myelin protein P0 in the Crb), or protein expression was altered only in the M28/W group (e.g., myosin light chain 3 and GPRIN family member 3 in the Crt, Thy-1 membrane glycoprotein, mitochondrial glutamate carrier 2, inter alpha-trypsin inhibitor heavy chain 4, keratin type I cytoskeletal 18, and keratin type II cytoskeletal 8 in the Hip, cAMP Regulated Phosphoprotein 21 (ARPP-21), cytochrome c oxidase subunit 6A1, plasminogen, serine proteinase inhibitor clade A member 3 C, alpha-1-antiproteinase, fibronectin, fetuin-B, and vitamin D-binding protein in the Str and zinc transporter 3 in the Crb) (Table S1). The same qualitative changes were found for four proteins in all parts of the brain examined. A version of cytochrome c oxidase subunit 2 (CcO2) and sideroflexin-3 were detected in M28 and M28/W, whereas an isoform of reticulon and an isoform of microtubule-associated protein 1A (MAP1A) were detected only in the control rats and not in the morphine-affected animals (M28 and M28/W). In parallel, similar qualitative changes were observed in a number of other proteins (Table S2).

4 Discussion

One of the main objectives of this study was to investigate the consequences of prolonged morphine administration and subsequent drug discontinuation on the redox state in the cerebral Crt, Hip, Str, and Crb of rats, as well as the possible effect of morphine on cell membrane damage determined by the detection of lipid peroxidation and protein carbonylation in selected brain regions. The extent of lipid peroxidation and protein carbonylation are commonly used markers of possible oxidative damage. In parallel, GSH levels were monitored in the same brain tissue samples. We observed some specific changes in some of the brain parts examined. Interestingly, plasma and mitochondrial membrane proteins were significantly oxidatively damaged only in the Crt. This damage persisted even after 7 days of morphine withdrawal. No changes in protein carbonylation were detected in other parts of the brain. This is partly in contrast to the results of a study by Sumathi et al., who observed increased protein carbonylation in rat whole brain homogenates after 21 days of morphine administration [14]. However, these authors used much higher doses of morphine (10–160 mg/kg/day) and did not differentiate between individual parts of the brain.

Whether chronic morphine use can cause oxidative brain damage remains controversial. There are essentially two main types of studies that have addressed this question. Some studies have demonstrated oxidative damage to the brain from chronic morphine use and have looked for substances that could mitigate this adverse effect. Conversely, other studies have not observed morphine-induced oxidative stress in the brain and have aimed to evaluate the potential protective effects of morphine against ischemia or neurodegenerative processes. There are two research groups investigating oxidative damage caused by chronic morphine. Motaghinejad et al. used a model based on the treatment of rats with morphine at a dose of 45 mg/kg/day for 4 weeks [15,48]. The same dosing regimen was used in a similar study by another research group [4]. In these studies, an increase in MDA and a decrease in the total amount of reduced GSH in the brain were observed. Similar results were obtained by Abdel-Zaher et al. in a mouse model and administration of morphine for 7 days at a dose of 5 mg/kg twice daily [11,12,13]. In contrast, the administration of morphine at a dose of 5 mg/kg/day for 6 consecutive days did not result in a change in MDA and a reduction in GSH in the brain of mice [49]. In rats, different effects were observed when 1 and 5 mg/kg/day were administered for 15 days. The low dose of morphine did not lead to an increase in MDA levels, in contrast to a higher dose [50]. Specific schedules of morphine administration led to different results in lipid peroxidation and GSH in rat brain [48]. Interestingly, contradictory results were found in the autopsied brains of chronic heroin users. Either an unchanged amount of GSH [16] or a decrease in GSH was found [51]. In contrast to the aforementioned observations, chronic administration of morphine alone did not result in an increase in lipid peroxidation in studies addressing the protective effects of morphine against oxidative stress. Chronic administration of morphine resulted in a decrease in lipid peroxidation after in vivo induced ischemia [22,52] or after the addition of H2O2 to cells in in vitro models [53]. The protocol of morphine administration appears to be an important factor influencing MDA production. The present results are broadly consistent with this knowledge. Our regimen of morphine administration resulted in a significant decrease in lipid peroxidation. This decrease persisted after 7 days of morphine withdrawal, except in the cerebral Crt, where MDA levels returned to control values. The decrease in lipid peroxidation cannot be explained by the mere reduction in total lipids, as the total lipid content was not changed. We were particularly interested in the lipids of the mitochondrial and plasma membrane. Obviously, cells must effectively protect these membranes from potential oxidative damage, so lipid peroxidation in these structures was reduced accordingly. A decrease in GSH in the cytosol was only observed in the Crt and Crb. In contrast, the amount of GSH was increased in the Str. Morphine has been shown to alter dopamine neurotransmission in the Str [54,55]. Interestingly, it has been reported that increased presynaptic dopamine turnover leads to the formation of deaminated metabolites and increased levels of oxidized GSH in the Str, but not in the frontal Crt [56]. Oral administration of GSH reduced infarct size in the cerebral ischemia/reperfusion model in rats by promoting the synthesis and inhibiting the degradation of intrastriatal dopamine. Administration of dopamine precursors had a similar effect on infarct size [57]. Our label-free determination of protein expression revealed an increased level of aromatic-l-amino-acid decarboxylase (P14173) in the Str. This may be suggested that the modification of dopamine neurotransmission by morphine could increase GSH levels in the Str.

Oxidative stress is caused by an increased production of reactive oxygen species (ROS). An important source of ROS in the cell is the respiratory chain [58]. Therefore, determining the expression of respiratory chain complexes was part of our main objective. Here, we observed a significant increase in the amount of CII in the Crt after morphine treatment. This increase may indicate an increased production of ROS by morphine in the Crt [59]. The increased production of ROS in the Crt of the M28 group could explain the increased carbonylation of proteins that was only detected in the Crt. Interestingly, the time course of morphine-induced changes in lipid peroxidation was also different in the Crt and in other parts of the brain studied. Although MDA formation in the Crt was reduced in the M28 group similarly to other parts of the brain, it returned to control levels 1 week after drug discontinuation, in contrast to the other parts of the brain. The reduced MDA formation observed in the brains of morphine-treated rats suggests an antioxidant effect of this drug. On the other hand, the increased expression of CII observed in the cerebral Crt after morphine administration could be associated with increased ROS production and the initiation of some compensatory mechanisms, which, in turn, could temporarily suppress MDA formation. These results indicate a greater vulnerability of the prefrontal Crt to the effects of morphine. In terms of addiction development, this result could imply further development of addiction by enhancing compulsive drug use and weakening volitional control [60].

The cellular redox state is also regulated by some enzymes that reduce ROS and thus act as antioxidant agents. Chronic administration of morphine has been shown to reduce the activity of some of these enzymes. The activity of SOD and GPx was decreased after 4 weeks of administration of high doses (45 mg/kg/day) of morphine [15,4]. In contrast, no decrease in the activities of these enzymes was observed in the studies dealing with morphine preconditioning. On the other hand, chronic administration of morphine had beneficial effects on the activity of antioxidant enzymes after ischemia. Ischemia significantly reduced enzyme activity, and morphine preconditioning suppressed this reduction [22,25]. For these reasons, we focused on the detection of these proteins to achieve our main goal. Our protocol of morphine administration (10 mg/kg/day, 28 days) did not result in changes in the expression of enzymes (CAT, SOD [Cu–Zn], mitochondrial SOD [Mn], brain nitric oxide synthase, GPx, peroxiredoxin-1,2,4,5,6, and mitochondrial thioredoxin-dependent peroxide reductase) that affect the cellular redox state (Table 1).

In the second aim of our study, we assessed the changes in protein expression determined by label-free protein quantification. Our data are consistent with other studies in which more proteins were downregulated than upregulated in the brain after morphine treatment [61,30].

The expression levels of some proteins were similarly altered in the different brain regions. The levels of two heat shock proteins (Hsp70 and Hspb1) were elevated. Similar results were reported for Hsp70 at both protein [50,62,63] and mRNA levels [64,65,66] and also for Hspb1 [66]. Both heat shock proteins are induced by a variety of noxious stimuli, such as ischemia, epileptic seizures, and hyperthermia, and confer protection to cells [67,68,69]. Elevated levels of Hsp70 protect against oxidative stress by reducing lipid peroxidation and increasing the activity of some enzymes that regulate cellular redox state [70,71]. It can be speculated that although the expression levels of redox enzymes were not altered, the long-term (28 days) upregulation of Hsp70 did not increase their activity and may contribute to a reduction in oxidative stress. The second question is whether upregulated Hsp70 could reduce the lipid peroxidation observed in our study. Ischemic postconditioning in the kidney reduced the adverse effects of ischemia such as lipid peroxidation, apoptosis, and inflammation by increasing the expression of Hsp70 and Hspb1 [72]. Another upregulated protein was PAD2. This enzyme catalyzes the conversion of arginine to citrulline. Its substrates include vimentin, myelin basic protein, and also histones. Increased activity of this enzyme has been found to be associated with multiple sclerosis, but also with Alzheimer’s disease [73]. Lange et al. reported that the inhibition of PAD2 reduced the extent of damage after a hypoxic–ischemic insult in neonates [74]. The question arises whether PAD2 expression increased by morphine contributes more to oxidative cell damage or whether it is related to gene transcription by histone modification [75]. The last increased protein detected in all parts of the brain was PLCdelta1. PLCdelta1 has been found to accumulate in filamentous inclusions in human neurodegenerative diseases [76]. The expression of PLCdelta1 has been shown to be increased by oxidative stress. However, the changes in the overall activity of PLCdelta1 are unclear [77,78]. The activity of PLCdelta1 may also be regulated by Gi/o proteins due to Ca2+ mobilization in cells [79]. Morphine treatment reduced the levels of flotillin-1 and flotillin-2, both of which are scaffold proteins associated with rafts. Their interactions enable the formation of multiprotein complexes and are therefore involved in a variety of cellular events from cell signaling, endocytosis, and protein trafficking to gene expression [80]. The link between flotillin and oxidative stress is related to neuroglobin, the protein that is cytoprotective in many ways [81]. One of these is the binding to flotillin-1 during oxidative stress and its function as a guanine nucleotide dissociation inhibitor for Gαi/o. This interaction is neuroprotective [82]. The link between neuroglobin, flotillin-1, and the Gi/o protein may be impaired by the administration of morphine, which acts via Gi/o proteins. Chronic morphine treatment under our experimental conditions resulted in a decrease in the expression of flotillin-1, but neuroglobin was not detected. Reduced expression of flotillin could affect the function of proteins associated with them, not only neuroglobin. Another downregulated protein was mGLUR2. Activation of mGLUR2 protects cells from oxidative stress damage after hypoxia–ischemia [83]. Under our experimental conditions, a decrease in mGLUR2 expression was observed in the M28 group and this decrease was more pronounced after withdrawal (RM28). Downregulation of mGLUR2 after morphine withdrawal has already been demonstrated in the nucleus accumbens, where this decrease in mGLUR2 expression abolished long-term depression [84]. Transgenic mGluR2-knockout rats showed a stronger dopamine response to heroin administration in the nucleus accumbens, higher locomotor activity, and stronger morphine analgesia. Thus, mGLUR2 has antiopioid effects [85,86]. The observed decrease in mGLUR2 expression could be responsible for the increasing dependence.

Interestingly, the protein expression profiles of all brain areas examined after 7 days of morphine withdrawal (M28/W) did not differ significantly from those of the M28 group. Only a few proteins were significantly altered. These results indicate that a 1 week morphine withdrawal does not lead to a normalization of protein levels and a return to the pre-dependence state. The common qualitative changes involved four proteins. CcO2 is part of complex IV of the respiratory chain. Only the CcO2 version Q5UAJ6 was detected in all parts of the brain of the M28 and RM28 groups. The other CcO2 detected did not change. This result is consistent with Western blot results, which did not show any significant changes in complex IV. The expression of the CcO2 version could be related to the inhibitory effect of morphine on cytochrome C oxidase activity. Morphine activates the production of NO [87], which subsequently inhibits cytochrome C oxidase [88]. Another protein that was only detected in M28 and RM28 was sideroflexin-3, which transports serine into the mitochondria. This is an important step in one-carbon metabolism [89]. 1C units of one-carbon C metabolism also serve to form NADPH, which is important for cell redox homeostasis [90,91]. The upregulation of sideroflexin-3 could increase NADPH production. Reticulon was not detected after morphine treatment and 7 day withdrawal. Reticulons are membrane proteins that are localized in the endoplasmic reticulum and have various functions [92]. MAP1A is preferentially localized in the dendrites of adult neurons, where it stabilizes microtubules [93]. The observed downregulation of MAP1A may partially reduce synaptic transduction. MAP1A-knockout mice showed the destabilization of dendritic structure, synaptic plasticity, and NMDA trafficking [94]. In the Crb, disruption of the MAP1A gene resulted in abnormal focal swelling of dendrite shafts and disruption of axon initial segment morphology [95].

Our analysis of the altered proteins using the DAVID database with respect to biological processes revealed a cluster of proteins that negatively regulate apoptotic processes in each part of the brain tested (Table S3). This group of proteins includes, in particular, Hsp70, Hspb1, and Nucleolar protein 3 (Nol3). The expression of all these proteins was increased. Hsp70, Hspb1, and Nol3 can inhibit apoptosis through numerous interactions with multiple mechanisms such as inhibition of caspases 3 and 9, inhibition of Bad and Bax, prevention of Bcl2 degradation, and inhibition of the JNK signaling pathway of apoptosis [96,97,98,99]. Hsp70 is involved in many processes, and its crucial role in neurodegeneration has also been described [100]. Increased Hspb1 expression may protect neurons after lumbosacral nerve root avulsion. This effect is due to the suppression of oxidative stress responses, as demonstrated in the SH-SY5Y model of benign and primary neuronal cultures exposed to oxygen–glucose deprivation [101]. A protective effect was also demonstrated in the cardiomyocyte line H9c2 after exposure to oxidative stress by H2O2 [102]. The protection of neuronal HT22 cells against oxidative stress induced by H2O2 administration was mediated by the regulation of apoptotic signaling pathways by added Nol3. Transduced Nol3 also protected against neuronal death in the CA1 region of the Hip in a model of ischemic injury [103]. Analysis of the data by cellular components revealed changes in extracellular space in the Hip, Str, and Crb (Table S4). The levels of most structural proteins related to extracellular space and exosome formation were reduced by morphine and its withdrawal in the Hip and Str, but also in the Crt, where the analysis did not identify this cluster due to the small number of protein changes (e.g., collagen alpha-1(I) chain, collagen alpha-2(I) chain, collagen type VI alpha 1 chain, flotillin-2, flotillin-1, fibronectin, reticulon). Similarly, cytoskeletal proteins and proteins that influence its composition and function were also reduced (e.g., spectrin, alpha, erythrocytic 1, MAP1A, myosin-6). A completely different situation was observed in the Crb. In this part of the brain, morphine induced an upregulation of structural proteins of the extracellular matrix and the cytoskeleton (e.g., collagen alpha-1(I) chain, collagen alpha-2(I) chain, collagen type VI alpha 1 chain, prolargin, fibronectin, biglycan, spectrin, alpha, erythrocytic 1, actin, alpha cardiac muscle 1, sorbin and SH3 domain-containing protein 2, erythrocyte membrane protein band 4.1). This difference is also evident in Fiure 3 and in the number of seven protein clusters detected by DAVID analysis focusing on cellular components (Table S4). In general, morphine administration leads to structural changes in the architecture of the brain. Our study shows that the Crb is most affected by structural changes. The observed upregulation of the extracellular matrix, cytoskeleton, and cytoskeleton-associated proteins in the Crb correlates well with morphological changes described previously [104]. Studies focusing on the effect of opioids on the extracellular matrix are not yet numerous [105]. Another approach to study changes in the extracellular matrix is to observe changes in extracellular vesicles. Morphine has caused changes in the composition of extracellular vesicles released by human brain microvascular endothelial cells. Pathway enrichment analysis revealed the “cell adhesion and extracellular matrix remodeling” process and the “HIF1 pathway”, a pathway related to oxidative stress responses [106]. Morphine-induced changes in the extracellular matrix were also detected by proteomic and phosphoproteomic analyses of proteins in a model of primary human astrocytes using liquid chromatography–electrospray ionization-mass spectrometry [31]. A 7 day morphine withdrawal showed a variety of protein changes. The levels of some proteins returned to control values or even fluctuated in the other direction. For some proteins, the effect was even more pronounced and changes were observed in other proteins that had not changed immediately after morphine withdrawal [9,10].

5 Conclusion

This study demonstrates that long-term treatment of rats with moderate doses of morphine leads to specific changes in the protein expression profile of different brain regions that do not return to normal after 7 days of drug withdrawal. In general, the monitored biochemical parameters and protein expression were not fundamentally altered. Only four qualitative changes in proteins common to all parts of the brain studied (cytochrome C oxidase subunit 2, sideroflexin-3, reticulon, and MAP1A) were detected in brain samples from rats withdrawn from morphine for 1  or 7 days compared to controls. Interestingly, glutathione levels were altered differently in the different brain regions and the observed significant increase in CII in the Crt was accompanied by increased protein carbonylation in this part of the brain, in contrast to the other brain regions studied. Our data suggest that long-term treatment with morphine specifically affects different brain regions and that a 1 week withdrawal of the drug is not sufficient to normalize protein levels and the cellular redox state. The data obtained expand our understanding of the potential adverse effects of morphine on the proteome and redox state of the brain and support the notion that morphine dosage plays an important role in the potential oxidative damage to cell membranes in the brain. A certain limitation of the study is that effects of morphine were only tested in male rats and that only a 1 week withdrawal period after discontinuation of the drug was investigated. Future studies looking at the long-term effects of morphine on the brain should also include female animals and longer withdrawal periods.

Acknowledgement

We thank Karel Harant and Pavel Talacko from Laboratory of Mass Spectrometry, Biocev, Charles University, Faculty of Science, for performing LC/MS analysis.

  1. Funding information: This work was supported by the Charles University Grant Agency, Project GA UK No. 377821, and by the Charles University Institutional Research Fund (SVV-260683).

  2. Author contributions: LH. and A.H. performed the experiments; L.H. and Z.D. analyzed the data; L.H. drafted the manuscript; J.N. designed the analysis workflow, revised and edited the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Zhang Y, Chen QY, Yu LC. Morphine: A protective or destructive role in neurons? Neuroscientist. 2008;14(6):561–70.10.1177/1073858408314434Suche in Google Scholar PubMed

[2] Skrabalova J, Karlovska I, Hejnova L, Novotny J. Protective effect of morphine against the oxidant-induced injury in H9c2 cells. Cardiovasc Toxicol. 2018;18(4):374–85.10.1007/s12012-018-9448-0Suche in Google Scholar PubMed

[3] Lu S, Liao LS, Zhang B, Yan WT, Chen LP, Yan H, et al. Antioxidant cascades confer neuroprotection in ethanol, morphine, and methamphetamine preconditioning. Neurochem Int. 2019;131:104540.10.1016/j.neuint.2019.104540Suche in Google Scholar PubMed

[4] Shibani F, Sahamsizadeh A, Fatemi I, Allahtavakoli M, Hasanshahi J, Rahmani M, et al. Effect of oleuropein on morphine-induced hippocampus neurotoxicity and memory impairments in rats. Naunyn-Schmiedebergs Arch Pharmacol. 2019;392(11):1383–91.10.1007/s00210-019-01678-3Suche in Google Scholar PubMed

[5] Ujcikova H, Dlouha K, Roubalova L, Vosahlikova M, Kagan D, Svoboda P. Up-regulation of adenylylcyclases I and II induced by long-term adaptation of rats to morphine fades away 20 days after morphine withdrawal. Biochimica Et Biophysica Acta-General Subj. 2011;1810(12):1220–9.10.1016/j.bbagen.2011.09.017Suche in Google Scholar PubMed

[6] Neugebauer NM, Einstein EB, Lopez MB, McClure-Begley TD, Mineur YS, Picciotto MR. Morphine dependence and withdrawal induced changes in cholinergic signaling. Pharmacol Biochem Behav. 2013;109:77–83.10.1016/j.pbb.2013.04.015Suche in Google Scholar PubMed PubMed Central

[7] Ujcikova H, Brejchova J, Vosahlikova M, Kagan D, Dlouha K, Sykora J, et al. Opioid-receptor (OR) signaling cascades in rat cerebral cortex and model cell lines: the role of plasma membrane structure. Physiol Res. 2014;63:S165–76.10.33549/physiolres.932638Suche in Google Scholar PubMed

[8] Garcia-Perez D, Lopez-Bellido R, Rodriguez RE, Laorden ML, Nunez C, Milanes MV. Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal. Brain Struct Funct. 2015;220(4):1901–19.10.1007/s00429-014-0761-5Suche in Google Scholar PubMed

[9] Drastichova Z, Hejnova L, Moravcova R, Novotny J. Proteomic analysis unveils expressional changes in cytoskeleton- and synaptic plasticity-associated proteins in rat brain six months after withdrawal from morphine. Life-Basel. 2021;11(7):683.10.3390/life11070683Suche in Google Scholar PubMed PubMed Central

[10] Ujcikova H, Eckhardt A, Hejnova L, Novotny J, Svoboda P. Alterations in the proteome and phosphoproteome profiles of rat hippocampus after six months of morphine withdrawal: comparison with the forebrain cortex. Biomedicines. 2022;10(1):80.10.3390/biomedicines10010080Suche in Google Scholar PubMed PubMed Central

[11] Abdel-Zaher AO, Abdel-Rahman MS, Elwasei FM. Blockade of nitric oxide overproduction and oxidative stress by nigella sativa oil attenuates morphine-induced tolerance and dependence in mice. Neurochem Res. 2010;35(10):1557–65.10.1007/s11064-010-0215-2Suche in Google Scholar PubMed

[12] Abdel-Zaher AO, Mostafa MG, Farghaly HSM, Hamdy MM, Abdel-Hady RH. Role of oxidative stress and inducible nitric oxide synthase in morphine-induced tolerance and dependence in mice. Effect of alpha-lipoic acid. Behav Brain Res. 2013;247:17–26.10.1016/j.bbr.2013.02.034Suche in Google Scholar PubMed

[13] Abdel-Zaher AO, Mostafa MG, Farghly HM, Hamdy MM, Omran GA, Al-Shaibani NKM. Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice. Eur J Pharmacol. 2013;702(1-3):62–70.10.1016/j.ejphar.2013.01.036Suche in Google Scholar PubMed

[14] Sumathi T, Nathiya VC, Sakthikumar M. Protective effect of bacoside-A against morphine-induced oxidative stress in rats. Ind J Pharm Sci. 2011;73(4):409–15.Suche in Google Scholar

[15] Motaghinejad M, Karimian M, Motaghinejad O, Shabab B, Yazdani I, Fatima S. Protective effects of various dosage of curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus. Pharmacol Rep. 2015;67(2):230–5.10.1016/j.pharep.2014.09.006Suche in Google Scholar PubMed

[16] Tong JC, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, et al. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug Alcohol Depend. 2018;190:20–8.10.1016/j.drugalcdep.2018.05.021Suche in Google Scholar PubMed PubMed Central

[17] Skrabalova J, Neckar J, Hejnova L, Bartonova I, Kolar F, Novotny J. Antiarrhythmic effect of prolonged morphine exposure is accompanied by altered myocardial adenylyl cyclase signaling in rats. Pharmacol Rep. 2012;64(2):351–9.10.1016/S1734-1140(12)70775-2Suche in Google Scholar

[18] Tanaka K, Kersten JR, Riess ML. Opioid-induced cardioprotection. Curr Pharm Des. 2014;20(36):5696–705.10.2174/1381612820666140204120311Suche in Google Scholar PubMed PubMed Central

[19] Headrick JP, Hoe LES, Du Toit EF, Peart JN. Opioid receptors and cardioprotection - ‘opioidergic conditioning’ of the heart. Br J Pharmacol. 2015;172(8):2026–50.10.1111/bph.13042Suche in Google Scholar PubMed PubMed Central

[20] Pak T, Cadet P, Mantione KJ, Stefano GB. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer’s disease. Med Sci Monit. 2005;11(10):BR357–BR66.Suche in Google Scholar

[21] Stetler RA, Leak RK, Gan Y, Li PY, Zhang F, Hu XM, et al. Preconditioning provides neuroprotection in models of CNS disease: Paradigms and clinical significance. Prog Neurobiol. 2014;114:58–83.10.1016/j.pneurobio.2013.11.005Suche in Google Scholar PubMed PubMed Central

[22] Arabian M, Aboutaleb N, Soleimani M, Ajami M, Habibey R, Pazoki-Toroudi H. Activation of mitochondrial KATP channels mediates neuroprotection induced by chronic morphine preconditioning in hippocampal CA-1 neurons following cerebral ischemia. Adv Med Sci. 2018;63(2):213–9.10.1016/j.advms.2017.11.003Suche in Google Scholar PubMed

[23] Huang JZ, Ren Y, Xu Y, Chen T, Xia TC, Li ZR, et al. The delta-opioid receptor and Parkinson’s disease. CNS Neurosci Ther. 2018;24(12):1089–99.10.1111/cns.13045Suche in Google Scholar PubMed PubMed Central

[24] Zhao XY, Li JF, Li TZ, Pan CX, Xue FS, Wang GY. Morphine pretreatment protects against cerebral ischemic injury via a cPKC gamma-mediated anti-apoptosis pathway. Exp Ther Med. 2021;22(3):1016.10.3892/etm.2021.10448Suche in Google Scholar PubMed PubMed Central

[25] Arabian M, Aboutaleb N, Soleimani M, Ajami M, Habibey R, Rezaei Y, et al. Preconditioning with morphine protects hippocampal CA1 neurons from ischemia-reperfusion injury via activation of the mTOR pathway. Can J Physiol Pharmacol. 2018;96(1):80–7.10.1139/cjpp-2017-0245Suche in Google Scholar PubMed

[26] Morris G, Berk M. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med. 2015;13:1016.10.1186/s12916-015-0310-ySuche in Google Scholar PubMed PubMed Central

[27] Tan SH, Karri V, Tay NWR, Chang KH, Ah HY, Ng PQ, et al. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease. Biomed Pharmacother. 2019;111:765–77.10.1016/j.biopha.2018.12.101Suche in Google Scholar PubMed

[28] Wang B, Su CJ, Liu TT, Zhou Y, Feng Y, Huang Y, et al. The neuroprotection of low-dose morphine in cellular and animal models of Parkinson’s disease through ameliorating endoplasmic reticulum (ER) stress and activating autophagy. Front Mol Neurosci. 2018;11:120.10.3389/fnmol.2018.00120Suche in Google Scholar PubMed PubMed Central

[29] Bodzon-Kulakowska A, Padrtova T, Drabik A, Ner-Kluza J, Antolak A, Kulakowski K, et al. Morphinome Database - The database of proteins altered by morphine administration - An update. J Proteom. 2019;190:21–6.10.1016/j.jprot.2018.04.013Suche in Google Scholar PubMed

[30] Ujcikova H, Cechova K, Jagr M, Roubalova L, Vosahlikova M, Svoboda P. Proteomic analysis of protein composition of rat hippocampus exposed to morphine for 10 days; comparison with animals after 20 days of morphine withdrawal. PLoS One. 2020;15(4):e0231721.10.1371/journal.pone.0231721Suche in Google Scholar PubMed PubMed Central

[31] Dozio V, Daali Y, Desmeules J, Sanchez JC. Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes. J Neurosci Res. 2022;100(1):220–36.10.1002/jnr.24731Suche in Google Scholar PubMed

[32] Drastichova Z, Skrabalova J, Neckar J, Kolar F, Novotny J. Prolonged morphine administration alters protein expression in the rat myocardium. J Biomed Sci. 2011;30:18.10.1186/1423-0127-18-89Suche in Google Scholar PubMed PubMed Central

[33] Drastichova Z, Skrabalova J, Jedelsky P, Neckar J, Kolar F, Novotny J. Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal. PLoS One. 2012;7(10):e47167.10.1371/journal.pone.0047167Suche in Google Scholar PubMed PubMed Central

[34] Adams JU, Holtzman SG. Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacol. 1990;100(4):451–8.10.1007/BF02243995Suche in Google Scholar PubMed

[35] Wolgin DL, Benson HD. Role of associative and nonassociative mechanisms in tolerance to morphine anorexia. Pharmacol Biochem Behav. 1991;39(2):279–86.10.1016/0091-3057(91)90180-ASuche in Google Scholar PubMed

[36] Kálmán J, Bjelik A, Hugyecz M, Tímár J, Gyarmati Z, Zana M, et al. 3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain. Int J Neuropsychopharmacol. 2007;10(2):183–90.10.1017/S146114570600650XSuche in Google Scholar PubMed

[37] Taracha E, Chrapusta SJ, Lehner M, Skórzewska A, Plaznik A. Methadone is substantially less effective than morphine in modifying locomotor and brain Fos responses to subsequent methadone challenge in rats. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(6):1032–9.10.1016/j.pnpbp.2009.05.015Suche in Google Scholar PubMed

[38] Tschacher W, Haemming R, Jacobshagen N. Time series modeling of heroin and morphine drug action. Psychopharmacol. 2003;165(2):188–93.10.1007/s00213-002-1271-3Suche in Google Scholar PubMed

[39] Hejnova L, Skrabalova J, Novotny J. Prolonged morphine treatment alters expression and plasma membrane distribution of beta-adrenergic receptors and some other components of their signaling system in rat cerebral cortex. J Mol Neurosci. 2017;63(3–4):364–76.10.1007/s12031-017-0987-9Suche in Google Scholar PubMed

[40] Stöhr J, Novotny J, Bourova L, Svoboda P. Modulation of adenylyl cyclase activity in young and adult rat brain cortex: Identification of suramin as a direct inhibitor of adenylyl cyclase. J Cell Mol Med. 2005;9(4):940–52.10.1111/j.1582-4934.2005.tb00390.xSuche in Google Scholar PubMed PubMed Central

[41] Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497–509.10.1016/S0021-9258(18)64849-5Suche in Google Scholar

[42] Cheng YS, Zheng Y, VanderGheynst JS. Rapid quantitative analysis of lipids using a colorimetric method in a microplate format. Lipids. 2011;46(1):95–103.10.1007/s11745-010-3494-0Suche in Google Scholar PubMed

[43] Mesquita CS, Oliveira R, Bento F, Geraldo D, Rodrigues JV, Marcos JC. Simplified 2,4-dinitrophenylhydrazine spectrophotometric assay for quantification of carbonyls in oxidized proteins. Anal Biochem. 2014;458:69–71.10.1016/j.ab.2014.04.034Suche in Google Scholar PubMed

[44] Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7.10.1016/0003-9861(59)90090-6Suche in Google Scholar PubMed

[45] Ihnatovych I, Hejnova L, Kostrnova A, Mares P, Svoboda P, Novotny J. Maturation of rat brain is accompanied by differential expression of the long and short splice variants of G(s)alpha protein: identification of cytosolic forms of G(s)alpha. J Neurochem. 2001;79(1):88–97.10.1046/j.1471-4159.2001.00544.xSuche in Google Scholar PubMed

[46] Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteom. 2014;13(9):2513–26.10.1074/mcp.M113.031591Suche in Google Scholar PubMed PubMed Central

[47] Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl Acids Res. 2009;37(1):1–13.10.1093/nar/gkn923Suche in Google Scholar PubMed PubMed Central

[48] Motaghinejad M, Karimian SM, Motaghinejad O, Shabab B, Asadighaleni M, Fatima S. The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats. Fund Clin Pharmacol. 2015;29(3):299–309.10.1111/fcp.12121Suche in Google Scholar PubMed

[49] Singh P, Sharma B, Gupta S, Sharma BM. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective K-ATP channel modulator. Psychopharmacol. 2015;232(2):465–75.10.1007/s00213-014-3680-5Suche in Google Scholar PubMed

[50] Joshi JC, Ray A, Gulati K. Differential modulatory effects of morphine on acute and chronic stress induced neurobehavioral and cellular markers in rats. Eur J Pharmacol. 2014;729:17–21.10.1016/j.ejphar.2014.01.058Suche in Google Scholar PubMed

[51] Gutowicz M, Kazmierczak B, Baranczyk-Kuzma A. The influence of heroin abuse on glutathione-dependent enzymes in human brain. Drug Alcohol Depend. 2011;113(1):8–12.10.1016/j.drugalcdep.2010.06.020Suche in Google Scholar PubMed

[52] Arabian M, Aboutaleb N, Ajami M, Habibey R. Interaction of mTOR and iNOS pathways in protection against Ischemia/Reperfusion injury. Iran J Pharm Res. 2019;18(2):785–92.Suche in Google Scholar

[53] Almeida MB, Costa-Malaquias A, Nascimento JLM, Oliveira KR, Herculano AM, Crespo-Lopez ME. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line. Braz J Med Biol Res. 2014;47(5):398–402.10.1590/1414-431X20143697Suche in Google Scholar

[54] Tjon GHK, Devries TJ, Ronken E, Hogenboom F, Wardeh G, Mulder AH, et al. Repeated and chtonix morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta-opioid andkappa-opioid receptor regulation. Eur J Pharmacol. 1994;252(2):205–12.10.1016/0014-2999(94)90598-3Suche in Google Scholar PubMed

[55] Haleem DJ, Nawaz S, Salman T. Dopamine and serotonin metabolism associated with morphine reward and its inhibition with buspirone: A study in the rat striatum. Pharmacol Biochem Behav. 2018;170:71–8.10.1016/j.pbb.2018.05.010Suche in Google Scholar PubMed

[56] Spina MB, Cohen G. Dopamine turnover and glutathione oxidation – implicationds for Parkinson disease. Proc Nat Acad Sci U S A. 1989;86(4):1398–400.10.1073/pnas.86.4.1398Suche in Google Scholar PubMed PubMed Central

[57] Wang H, Du YS, Xu WS, Li CJ, Sun H, Hu KR, et al. Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine. Acta Pharmacol Sin. 2022;43(3):541–1.10.1038/s41401-021-00650-3Suche in Google Scholar PubMed PubMed Central

[58] Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019;44(1):3–15.10.3892/ijmm.2019.4188Suche in Google Scholar PubMed PubMed Central

[59] Grivennikova VG, Kozlovsky VS, Vinogradov AD. Respiratory complex II: ROS production and the kinetics of ubiquinone reduction. Biochim Biophys Acta-Bioenergetics. 2017;1858(2):109–17.10.1016/j.bbabio.2016.10.008Suche in Google Scholar PubMed

[60] Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69.10.1038/nrn3119Suche in Google Scholar PubMed PubMed Central

[61] Korostynski M, Piechota M, Kaminska D, Solecki W, Przewlocki R. Morphine effects on striatal transcriptome in mice. Gen Biol. 2007;8(6):R128.10.1186/gb-2007-8-6-r128Suche in Google Scholar PubMed PubMed Central

[62] Yang HY, Pu XP, Liu Y. Chronic morphine treatment induces over-expression of HSP70 in mice striatum related with abnormal ubiquitin-proteasome degradation. Drug Alcohol Depend. 2014;139:53–9.10.1016/j.drugalcdep.2014.03.005Suche in Google Scholar PubMed

[63] Qin WJ, Zhang L, Tang K, Zhao L, Mao M, Wang YT, et al. Effect of heat shock protein 70 modulators on the development of morphine analgesic tolerance in rats. Behav Pharmacol. 2020;31(2–3):179–85.10.1097/FBP.0000000000000528Suche in Google Scholar PubMed PubMed Central

[64] Ammon S, Mayer P, Riechert U, Tischmeyer H, Hollt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol Brain Res. 2003;112(1-2):113–25.10.1016/S0169-328X(03)00057-3Suche in Google Scholar

[65] Ammon-Treiber S, Grecksch G, Stumm R, Riechert U, Tischmeyer H, Reichenauer A, et al. Rapid, transient, and dose-dependent expression of Hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones. 2004;9(2):182–97.10.1379/CSC-42.1Suche in Google Scholar PubMed PubMed Central

[66] Parkitna JMR, Bilecki W, Mierzejewski P, Stefanski R, Ligeza A, Bargiela A, et al. Effects of morphine on gene expression in the rat amygdala. J Neurochem. 2004;91(1):38–48.10.1111/j.1471-4159.2004.02697.xSuche in Google Scholar PubMed

[67] Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperth. 2005;21(5):379–92.10.1080/02656730500069955Suche in Google Scholar PubMed

[68] Behdarvandy M, Karimian M, Atlasi MA, Tameh AA. Heat shock protein 27 as a neuroprotective biomarker and a suitable target for stem cell therapy and pharmacotherapy in ischemic stroke. Cell Biol Int. 2020;44(2):356–67.10.1002/cbin.11237Suche in Google Scholar PubMed

[69] Kim JY, Kim JW, Yenari MA. Heat shock protein signaling in brain ischemia and injury. Neurosci Lett. 2020;715:134642.10.1016/j.neulet.2019.134642Suche in Google Scholar PubMed PubMed Central

[70] Guo SH, Wharton W, Moseley P, Shi HL. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones. 2007;12(3):245–54.10.1379/CSC-265.1Suche in Google Scholar PubMed PubMed Central

[71] Kim W, Kwon HJ, Jung HY, Yoo DY, Moon SM, Kim DW, et al. Tat-HSP70 protects neurons from oxidative damage in the NSC34 cells and ischemic damage in the ventral horn of rabbit spinal cord. Neurochem Int. 2019;129:104477.10.1016/j.neuint.2019.104477Suche in Google Scholar PubMed

[72] Guo QM, Du XF, Zhao YL, Zhang D, Yue LH, Wang ZX. Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats. Mol Med Rep. 2014;10(6):2875–81.10.3892/mmr.2014.2641Suche in Google Scholar PubMed PubMed Central

[73] Witalison EE, Thompson PR, Hofseth LJ. Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation. Curr Drug Targets. 2015;16(7):700–10.10.2174/1389450116666150202160954Suche in Google Scholar PubMed PubMed Central

[74] Lange S, Rocha-Ferreira E, Thei L, Mawjee P, Bennett K, Thompson PR, et al. Peptidylariginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates. J Neurochem. 2014;130(4):555–62.10.1111/jnc.12744Suche in Google Scholar PubMed PubMed Central

[75] Beato M, Sharma P. Peptidyl arginine deiminase 2 (PADI2)-mediated arginine citrullination modulates transcription in cancer. Int J Mol Sci. 2020;21(4):1351.10.3390/ijms21041351Suche in Google Scholar PubMed PubMed Central

[76] Shimohama S, Perry G, Richey P, Takenawa T, Whitehouse PJ, Miyoshi K, et al. Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases. Neurosci Lett. 1993;162(1–2):183–6.10.1016/0304-3940(93)90591-8Suche in Google Scholar PubMed

[77] Tanino H, Shimohama S, Sasaki Y, Sumida Y, Fujimoto S. Increase in phospholipase C-delta 1 protein levels in aluminum-treated rat brains. Biochem Biophys Res Commun. 2000;271(3):620–5.10.1006/bbrc.2000.2679Suche in Google Scholar PubMed

[78] Tanino H, Kusuda T, Nagasawa K, Shimohama S, Fujimoto S. Alterations of phospholipase C isozymes in rat cerebral cortex through hyperoxia. Biol Pharma Bull. 2001;24(11):1241–5.10.1248/bpb.24.1241Suche in Google Scholar PubMed

[79] Murthy KS, Zhou HP, Huang J, Pentyala SN. Activation of PLC-delta 1 by G(i/o)-coupled receptor agonists. Am J Physiol-Cell Physiol. 2004;287(6):C1679–C87.10.1152/ajpcell.00257.2004Suche in Google Scholar PubMed

[80] Kwiatkowska K, Matveichuk OV, Fronk J, Ciesielska A. Flotillins: at the intersection of protein s-palmitoylation and lipid-mediated signaling. Int J Mol Sci. 2020;21(7):2283.10.3390/ijms21072283Suche in Google Scholar PubMed PubMed Central

[81] Van Acker ZP, Luyckx E, Dewilde S. Neuroglobin expression in the brain: a story of tissue homeostasis preservation. Mol Neurobiol. 2019;56(3):2101–22.10.1007/s12035-018-1212-8Suche in Google Scholar PubMed

[82] Watanabe S, Takahashi N, Uchida H, Wakasugi K. Human neuroglobin functions as an oxidative stress-responsive sensor for neuroprotection. J Biol Chem. 2012;287(36):30128–38.10.1074/jbc.M112.373381Suche in Google Scholar PubMed PubMed Central

[83] Bratek E, Ziembowicz A, Bronisz A, Salinska E. The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia. PLoS One. 2018;13(7):e0200933.10.1371/journal.pone.0200933Suche in Google Scholar PubMed PubMed Central

[84] Qian ZQ, Wu XJ, Qiao YN, Shi MM, Liu ZQ, Ren W, et al. Downregulation of mGluR2/3 receptors during morphine withdrawal in rats impairs mGluR2/3-and NMDA receptor-dependent long-term depression in the nucleus accumbens. Neurosci Lett. 2019;690:76–82.10.1016/j.neulet.2018.10.018Suche in Google Scholar PubMed

[85] Qian L, Tan KS, Wei SJ, Wu HM, Xu ZL, Wilson B, et al. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol. 2007;179(2):1198–209.10.4049/jimmunol.179.2.1198Suche in Google Scholar PubMed

[86] Gao JT, Jordan CJ, Bi GH, He Y, Yang HJ, Gardner EL, et al. Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats. Neuropsychopharmacol. 2018;43(13):2615–26.10.1038/s41386-018-0231-5Suche in Google Scholar PubMed PubMed Central

[87] Toda N, Kishioka S, Hatano Y, Toda H. Modulation of opioid actions by nitric oxide signaling. Anesthesiology. 2009;110(1):166–81.10.1097/ALN.0b013e31819146a9Suche in Google Scholar PubMed

[88] Poderoso JJ, Helfenberger K, Poderoso C. The effect of nitric oxide on mitochondrial respiration. Nitric Oxide-Biol Chem. 2019;88:61–72.10.1016/j.niox.2019.04.005Suche in Google Scholar PubMed

[89] Kory N, Wyant GA, Prakash G, de Bos JU, Bottanelli F, Pacold ME, et al. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. Science. 2018;362(6416):eaat9528.10.1126/science.aat9528Suche in Google Scholar PubMed PubMed Central

[90] Fan J, Ye JB, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014;510(7504):298–302.10.1038/nature13236Suche in Google Scholar PubMed PubMed Central

[91] Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25(1):27–42.10.1016/j.cmet.2016.08.009Suche in Google Scholar PubMed PubMed Central

[92] Pradhan LK, Das SK. The Regulatory Role of Reticulons in Neurodegeneration: Insights Underpinning Therapeutic Potential for Neurodegenerative Diseases. Cell Mol Neurobiol. 2020;41(6):1157–74.10.1007/s10571-020-00893-4Suche in Google Scholar PubMed

[93] Halpain S, Dehmelt L. The MAPI family of microtubule-associated proteins. Gen. Biol. 2006;7(6):224.10.1186/gb-2006-7-6-224Suche in Google Scholar PubMed PubMed Central

[94] Takei Y, Kikkawa YS, Atapour N, Hensch TK, Hirokawa N. Defects in synaptic plasticity, reduced NMDA-receptor transport, and instability of postsynaptic density proteins in mice lacking microtubule-associated protein 1A. J Neurosci. 2015;35(47):15539–54.10.1523/JNEUROSCI.2671-15.2015Suche in Google Scholar PubMed PubMed Central

[95] Liu Y, Lee JW, Ackerman SL. Mutations in the microtubule-associated protein 1A (Map1a) gene cause Purkinje cell degeneration. J Neurosci. 2015;35(11):4587–98.10.1523/JNEUROSCI.2757-14.2015Suche in Google Scholar PubMed PubMed Central

[96] Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (Hsp70) as an emerging drug target. J Med Chem. 2010;53(12):4585–602.10.1021/jm100054fSuche in Google Scholar PubMed PubMed Central

[97] Vidyasagar A, Wilson NA, Djamali A. Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair. 2012;5(1):7.10.1186/1755-1536-5-7Suche in Google Scholar PubMed PubMed Central

[98] Venugopal A, Sundaramoorthy K, Vellingiri B. Therapeutic potential of Hsp27 in neurological diseases. Egyptian. J Med Hum Genet. 2019;20(1):21.10.1186/s43042-019-0023-4Suche in Google Scholar

[99] Zhang J, Zheng XX, Wang PY, Wang JX, Ding W. Role of apoptosis repressor with caspase recruitment domain (ARC) in cell death and cardiovascular disease. Apoptosis. 2021;26(1–2):24–37.10.1007/s10495-020-01653-xSuche in Google Scholar PubMed

[100] Ghosh S, Vashisth K, Ghosh S, Han SS, Bhaskar R, Sinha JK. From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in maintaining cellular homeostasis and potential therapeutic implications. J Biomol Struct Dyn. 2023;1–12.10.1080/07391102.2023.2252509Suche in Google Scholar PubMed

[101] Zhou ZB, Huang GX, Lu JJ, Ma J, Yuan QJ, Cao Y, et al. Up-regulation of heat shock protein 27 inhibits apoptosis in lumbosacral nerve root avulsion-induced neurons. Sci Rep. 2019;9(1):11468.10.1038/s41598-019-48003-9Suche in Google Scholar PubMed PubMed Central

[102] Wang N, Liu XH, Liu K, Wang KK, Zhang HL. Homo-oxidized HSPB1 protects H9c2 cells against oxidative stress via activation of KEAP1/NRF2 signaling pathway. Iscience. 2023;26(8):107443.10.1016/j.isci.2023.107443Suche in Google Scholar PubMed PubMed Central

[103] Sohn EJ, Shin MJ, Eum WS, Kim DW, Yong JI, Ryu EJ, et al. Tat-NOL3 protects against hippocampal neuronal cell death induced by oxidative stress through the regulation of apoptotic pathways. Int J Mol Med. 2016;38(1):225–35.10.3892/ijmm.2016.2596Suche in Google Scholar PubMed

[104] Bekheet SH, Saker SA, Abdel-Kader AM, Younis AEA. Histopathological and biochemical changes of morphine sulphate administration on the cerebellum of albino rats. Tissue Cell. 2010;42(3):165–75.10.1016/j.tice.2010.03.005Suche in Google Scholar PubMed

[105] Ray MH, Williams BR, Kuppe MK, Bryant CD, Logan RW. A Glitch in the matrix: the role of extracellular matrix remodeling in opioid use disorder. Front Integr Neurosci. 2022;16:899637.10.3389/fnint.2022.899637Suche in Google Scholar PubMed PubMed Central

[106] Vujic T, Schvartz D, Furlani IL, Meister I, González-Ruiz V, Rudaz S, et al. Oxidative stress and extracellular matrix remodeling are signature pathways of extracellular vesicles released upon morphine exposure on human brain microvascular endothelial cells. Cells. 2022;11(23):3926.10.3390/cells11233926Suche in Google Scholar PubMed PubMed Central

Received: 2023-10-11
Revised: 2024-03-06
Accepted: 2024-03-17
Published Online: 2024-04-20

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
https://doi.org/10.1515/biol-2022-0858
Schlagwörter für diesen Artikel
morphine; withdrawal; brain; oxidative stress; proteomics
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0858/html
Button zum nach oben scrollen